677 related articles for article (PubMed ID: 30955282)
21. Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis.
Chalmers JD; McHugh BJ; Docherty C; Govan JR; Hill AT
Thorax; 2013 Jan; 68(1):39-47. PubMed ID: 23076388
[TBL] [Abstract][Full Text] [Related]
22. Sputum pathogen spectrum and clinical outcomes of upper respiratory tract infection in bronchiectasis exacerbation: a prospective cohort study.
Huang Y; Chen CL; Cen LJ; Li HM; Lin ZH; Zhu SY; Duan CY; Zhang RL; Pan CX; Zhang XF; Zhang XX; He ZF; Shi MX; Zhong NS; Guan WJ
Emerg Microbes Infect; 2023 Dec; 12(1):2202277. PubMed ID: 37038356
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory Responses, Spirometry, and Quality of Life in Subjects With Bronchiectasis Exacerbations.
Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Li HM; Lin ZM; Jiang M; Zheng JP; Chen RC; Zhong NS
Respir Care; 2015 Aug; 60(8):1180-9. PubMed ID: 26060319
[TBL] [Abstract][Full Text] [Related]
24. Respiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment Test.
Dai MY; Qiao JP; Xu YH; Fei GH
Int J Chron Obstruct Pulmon Dis; 2015; 10():2257-63. PubMed ID: 26527871
[TBL] [Abstract][Full Text] [Related]
25. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens.
Kawamatawong T; Apiwattanaporn A; Siricharoonwong W
Int J Chron Obstruct Pulmon Dis; 2017; 12():1625-1630. PubMed ID: 28615935
[TBL] [Abstract][Full Text] [Related]
26. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study.
Perotin JM; Dury S; Renois F; Deslee G; Wolak A; Duval V; De Champs C; Lebargy F; Andreoletti L
J Med Virol; 2013 May; 85(5):866-73. PubMed ID: 23447038
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic-resistant
Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():237-246. PubMed ID: 29386892
[TBL] [Abstract][Full Text] [Related]
28. Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations.
Chin M; De Zoysa M; Slinger R; Gaudet E; Vandemheen KL; Chan F; Hyde L; Mah TF; Ferris W; Mallick R; Aaron SD
J Cyst Fibros; 2015 Jul; 14(4):482-9. PubMed ID: 25544473
[TBL] [Abstract][Full Text] [Related]
29. Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples.
Alotaibi NM; Chen V; Hollander Z; Leipsic JA; Hague CJ; Murphy DT; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
Int J Chron Obstruct Pulmon Dis; 2019; 14():311-319. PubMed ID: 30774328
[TBL] [Abstract][Full Text] [Related]
30. Viruses are frequently present as the infecting agent in acute exacerbations of chronic obstructive pulmonary disease in patients presenting to hospital.
Biancardi E; Fennell M; Rawlinson W; Thomas PS
Intern Med J; 2016 Oct; 46(10):1160-1165. PubMed ID: 27515577
[TBL] [Abstract][Full Text] [Related]
31. Investigation of bronchiectasis in severe uncontrolled asthma.
Dimakou K; Gousiou A; Toumbis M; Kaponi M; Chrysikos S; Thanos L; Triantafillidou C
Clin Respir J; 2018 Mar; 12(3):1212-1218. PubMed ID: 28544140
[TBL] [Abstract][Full Text] [Related]
32. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
[TBL] [Abstract][Full Text] [Related]
33. [Etiology of acute respiratory tract infection in hospitalized children in Suzhou from 2005 to 2011].
Ji W; Chen ZR; Zhou WF; Sun HM; Li BQ; Cai LH; Yan YD
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Jun; 47(6):497-503. PubMed ID: 24113096
[TBL] [Abstract][Full Text] [Related]
34. Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection.
Bellinghausen C; Gulraiz F; Heinzmann AC; Dentener MA; Savelkoul PH; Wouters EF; Rohde GG; Stassen FR
Respir Res; 2016 Jun; 17(1):68. PubMed ID: 27259950
[TBL] [Abstract][Full Text] [Related]
35. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
[TBL] [Abstract][Full Text] [Related]
36. Impulse oscillometry in adults with bronchiectasis.
Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Li HM; Lin ZM; Zheng JP; Chen RC; Zhong NS
Ann Am Thorac Soc; 2015 May; 12(5):657-65. PubMed ID: 25654540
[TBL] [Abstract][Full Text] [Related]
37. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis.
Kapur N; Grimwood K; Masters IB; Morris PS; Chang AB
Pediatr Pulmonol; 2012 Mar; 47(3):300-7. PubMed ID: 21901858
[TBL] [Abstract][Full Text] [Related]
38. Is there a role of viral infection in cystic fibrosis exacerbation in children?
Hamed DH; Soliman MS; Emam OS; El-Attar MM
Turk J Pediatr; 2022; 64(3):549-557. PubMed ID: 35899568
[TBL] [Abstract][Full Text] [Related]
39. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
40. Sputum matrix metalloproteinase-8 and -9 and tissue inhibitor of metalloproteinase-1 in bronchiectasis: clinical correlates and prognostic implications.
Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Gu YY; Liu GH; Li HM; Chen RC; Zhong NS
Respirology; 2015 Oct; 20(7):1073-81. PubMed ID: 26122009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
